Methoxsalen Market

Methoxsalen Market Size, Share & Industry Analysis, By Source:-(Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User:-(Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Methoxsalen market is projected to grow at a CAGR of 4.6% from 2025 to 2035, fueled by increasing use in dermatology and photopheresis for immune-related disorders. Methoxsalen (also known as 8-methoxypsoralen) is a psoralen compound used in combination with UVA light (PUVA therapy) to treat skin conditions such as psoriasis, vitiligo, and cutaneous T-cell lymphoma (CTCL). It works by intercalating into DNA and forming cross-links when activated by UVA radiation, leading to localized immune modulation or cytotoxicity.

The demand for Methoxsalen is driven by the rising global prevalence of autoimmune and pigmentary skin disorders, growing acceptance of photochemotherapy as a treatment option, and expansion of extracorporeal photopheresis (ECP) in treating graft-versus-host disease (GVHD) and organ transplant rejection. Its utility in both dermatology and immunotherapy provides a steady dual-market presence.

Regionally, North America dominates the Methoxsalen market due to a high number of PUVA therapy centers, clinical awareness, and established treatment guidelines for CTCL and GVHD. Europe also shows strong adoption, especially in France and Germany, due to expanded ECP applications. The Asia-Pacific region is projected to witness significant growth due to increasing vitiligo and psoriasis incidence, rising dermatologic treatment access, and regional expansion of advanced phototherapy technologies.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Methoxsalen
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Key End-Use Industries
- Pharmaceutical Industry.
- Hospitals & Clinics.
- Research Institutions.

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

May 14, 2025

What is Methoxsalen?

Methoxsalen (also known as 8-Methoxypsoralen) is a photosensitizing agent used in combination with UVA radiation therapy (known as PUVA therapy) for the treatment of skin disorders such as vitiligo, psoriasis, eczema, and cutaneous T-cell lymphoma. It works by intercalating into DNA and, upon UVA exposure, forming crosslinks that inhibit DNA replication, thus reducing abnormal cell proliferation. It is available in oral, topical, and injectable formulations, and is used under controlled clinical settings due to its photosensitivity risks.

What is the market growth of Methoxsalen?

The global Methoxsalen market is expected to grow at a CAGR of 4.9% from 2025 to 2035, rising from approximately USD 135 million in 2025 to USD 220 million by 2035. Growth is driven by the increasing prevalence of chronic skin conditions, growing demand for phototherapy, and expanded dermatological applications in both developed and emerging markets.

What are the drivers of the Methoxsalen market?

Key drivers include the rising incidence of autoimmune skin diseases, particularly psoriasis and vitiligo, the increased adoption of PUVA therapy, and advances in dermatological laser and light treatment devices. Methoxsalen is also favored for its cost-effective therapeutic role in conditions unresponsive to topical or biologic therapies. Additionally, greater awareness of skin health and pigmentation disorders supports market growth.

Who are the key players operating in the Methoxsalen market?

Major manufacturers include Valeant Pharmaceuticals (Bausch Health), Taj Pharmaceuticals, Zydus Lifesciences, Hikma Pharmaceuticals, and Glenmark Pharmaceuticals. These companies produce both branded and generic versions for dermatological and oncological applications, with distribution through hospital dermatology departments, specialty clinics, and pharmacies.

Which region will exhibit the fastest growth in the Methoxsalen market?

Asia-Pacific is anticipated to witness the fastest growth due to high population density, growing cases of vitiligo and psoriasis, and increased access to light-based therapies. North America and Europe maintain strong demand due to advanced dermatology services, well-established phototherapy clinics, and clinical trial activity related to pigmentary and lymphoproliferative diseases.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com